Federal contract award
89303924FEM000268
BPA CALL WILL BE PLACED AGAINST BLANKET PURCHASE AGREEMENT (BPA) 89303923AEM000018 WITH 89303924FEM000268 TO PROVIDE AMSE FACILITY REPRESENTATIVE SUPPORT SERVICES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Energy |
| Office | HANFORD FIELD OFFICE |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R699 — Other Administrative Support Services |
| Parent award / vehicle | 89303923AEM000018 |
| Set-aside | Not reported |
| Pricing type | TIME AND MATERIALS |
| Obligations | $2.4M |
| Current contract value | $2.4M |
| Potential contract value / ceiling | $2.4M |
| Start date | Dec 1, 2023 |
| Current end date | Nov 30, 2026 |
| Potential end date | Nov 30, 2026 |
| Latest award activity | Sep 18, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 18, 2025 | P00008 | $807.0K | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 2 AND ADD INCREMENTAL FUNDING IN THE AMOUNT OF $778,886.40 FOR SERVICES AND $28,138.77 FOR ODCS. |
| Jun 12, 2025 | P00007 | $67.9K | THE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE $67,890.77 TO CLIN 10001. |
| Mar 6, 2025 | P00006 | $370.0K | THE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE $370,000.00 TO CLIN 10001. FURTHERMORE, PROGRAM OFFICIAL (PO) CHANGED TO LORI GAMACHE. |
| Oct 31, 2024 | P00005 | $345.0K | THE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE $316,861.23,000 TO CLIN 10001 AND $28,138.77 TO CLIN 10002, WHICH TOTALS $345,000. ADDITIONALLY, THIS MODIFICATION ALSO UPDATES THE USE OF THE SITE FIELD OFFICE NAMES IN ALIGNMENT WITH THE RECOMBINATION |
| Sep 9, 2024 | P00004 | $25.3K | THE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE $25,335.78 TO CLIN 00001. |
| Jul 15, 2024 | P00003 | $220.3K | THE PURPOSE OF THIS MODIFICATION IS TO OBLIGATE $220,328.00 TO CLIN 00001. ADDITIONALLY, EACH LABOR CLIN WILL BE REDUCED BY THE PROPOSED AMOUNT LESS $25,335.78 FOR THE BASE PERIOD ONLY (ALREADY INVOICED AMOUNT) FOR 1 FTE AS THE FTE WAS NOT BACKFILLED |
| Apr 17, 2024 | P00002 | $190.0K | THE PURPOSE OF THIS MODIFICATION IS OBLIGATE $190,000.00 TO CLIN 00001. |
| Feb 29, 2024 | P00001 | $28.1K | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE SOW WITH REQUIRED TRAININGS AND ADD ODC CLINS TO EACH PERIOD USING THE RECEIVED TRAINING QUOTE FROM CAS. ADDITIONALLY, $28,138.77 WILL BE OBLIGATED TO THE BASE YEAR ODC CLIN. |
| Nov 15, 2023 | 0 | $321.0K | BPA CALL WILL BE PLACED AGAINST BLANKET PURCHASE AGREEMENT (BPA) 89303923AEM000018 WITH 89303924FEM000268 TO PROVIDE AMSE FACILITY REPRESENTATIVE SUPPORT SERVICES. |
Estimated positioning window
Nov 1, 2026 – Jan 30, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2026-11-30 (29 days from calculation)
- +35 points
- 159 historical awards in this buyer and category group
- +15 points
- 9 recorded award transactions
- +10 points
- Latest award action: 2025-09-18
- +0 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.